カテゴリ： MarketLine, ドイツ, 企業調査

Bayer AG：企業の戦略・SWOT・財務情報

◆英語タイトル：Bayer AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15444
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：65
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Bayer AG – Strategy, SWOT and Corporate Finance Report
Summary

Bayer AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bayer (or ‘the group’) is a Germany-based global chemical and pharmaceutical business group. It operates in Asia Pacific, Europe, North America, Latin America, Africa, and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Scope

- Detailed information on Bayer AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bayer AG in the form of a SWOT analysis
- An in-depth view of the business model of Bayer AG including a breakdown and examination of key business segments
- Intelligence on Bayer AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bayer AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bayer AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bayer AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bayer AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Bayer AG: Company Overview
Bayer AG: Overview and Key Facts
Bayer AG: Overview
Bayer AG: Key Facts
Bayer AG: Key Employees
Bayer AG: Key Employee Biographies
Bayer AG: Major Products and Services
Bayer AG: Company History
Bayer AG: Management Statement
Bayer AG: Locations and Subsidiaries
Bayer AG: Key Competitors
Bayer AG: Company Analysis
Bayer AG: Business Description
Bayer AG: SWOT Analysis
Bayer AG: SWOT Overview
Bayer AG: Strengths
Bayer AG: Weaknesses
Bayer AG: Opportunities
Bayer AG: Threats
Bayer AG: Corporate Financial Deals Activity
Bayer AG: Financial Deals Overview
Bayer AG: Targets and Partners
Bayer AG: Top Deals 2015 – 2019YTD*
Bayer AG: Advisors
Bayer AG: Top Legal Advisors
Bayer AG: Top Financial Advisors
Bayer AG: Mergers and Acquisitions
Bayer AG: Corporate Venturing
Bayer AG: Capital Raising
Bayer AG: Partnership
Bayer AG: Divestments
Bayer AG: Private Equity and Ownership
Bayer AG: Recent Developments
Bayer AG: News and Events Summary
Bayer AG: Business Expansion
Bayer AG: Business Reorganization
Bayer AG: Contracts
Bayer AG: Corporate Governance
Bayer AG: Financial Deals
Bayer AG: Grants
Bayer AG: IT Spending Announcements
Bayer AG: Regulatory and Legal Events
Bayer AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Bayer AG: Key Facts
Table 2: Bayer AG: Key Employees
Table 3: Bayer AG: Company History
Table 4: Bayer AG: Locations and Subsidiaries
Table 5: Bayer AG: Key Competitors
Table 6: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Bayer AG: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Bayer AG: M&A Average Deal Size - Value (US$m)
Table 9: Bayer AG: Targets and Partners
Table 10: Bayer AG: Top Deals 2015 - 2019YTD*
Table 11: Bayer AG: Legal Advisor Ranking by Value (US$m)
Table 12: Bayer AG: Financial Advisor Ranking by Value (US$m)
Table 13: Bayer AG: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: Bayer AG: M&A Activity by Geography (2015 - YTD*2019)
Table 15: Bayer AG: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: Bayer AG: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: Bayer AG: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: Bayer AG: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: Bayer AG: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: Bayer AG: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: Bayer AG: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 22: Bayer AG: Divestments by Geography (2015 - YTD*2019)
Table 23: Bayer AG: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Table 24: Bayer AG: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)
Table 25: Bayer AG: News and Events Summary
Table 26: Bayer AG: Business Expansion
Table 27: Bayer AG: Business Reorganization
Table 28: Bayer AG: Contracts
Table 29: Bayer AG: Corporate Governance
Table 30: Bayer AG: Financial Deals
Table 31: Bayer AG: Grants
Table 32: Bayer AG: IT Spending Announcements
Table 33: Bayer AG: Regulatory and Legal Events
Table 34: Bayer AG: Strategy and Operations

List of Figures
Figure 1: Bayer AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bayer AG: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Bayer AG: M&A Average Deal Size - Value (US$m)
Figure 4: Bayer AG: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: Bayer AG: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: Bayer AG: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: Bayer AG: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: Bayer AG: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: Bayer AG: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: Bayer AG: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: Bayer AG: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 12: Bayer AG: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 13: Bayer AG: Divestments by Geography (2015 - YTD*2019)
Figure 14: Bayer AG: Private Equity and Ownership Volume and Value Trend (2015 - YTD*2019)
Figure 15: Bayer AG: Private Equity and Ownership Volume by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[Bayer AG：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Air Liquide Welding France, S.A.：企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • OGE Energy Corp：企業の戦略・SWOT・財務情報
    OGE Energy Corp - Strategy, SWOT and Corporate Finance Report Summary OGE Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ARCA biopharma Inc (ABIO)：企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Colgate-Palmolive Company：戦略・SWOT・企業財務分析
    Colgate-Palmolive Company - Strategy, SWOT and Corporate Finance Report Summary Colgate-Palmolive Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Centene Corp (CNC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • PT Dirgantara Indonesia：企業の戦略・SWOT・財務情報
    PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Dirgantara Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Northern Technologies International Corporation (NTIC)：企業の財務・戦略的SWOT分析
    Northern Technologies International Corporation (NTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Costco Wholesale UK Limited：企業の戦略・SWOT・財務分析
    Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Premier Gold Mines Limited：企業の戦略・SWOT・財務情報
    Premier Gold Mines Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Gold Mines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shield Therapeutics Plc (STX)：企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • NovoCure Ltd (NVCR)：製薬・医療：M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Dignitana AB (DIGN)：企業の財務・戦略的SWOT分析
    Dignitana AB (DIGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Community Bank System Inc (CBU)：企業の財務・戦略的SWOT分析
    Community Bank System Inc (CBU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Soitec SA (SOI)-エネルギー分野：企業M&A・提携分析
    Summary Soitec S.A. (Soitec) is a designer and manufacturer of semiconductor materials. The company offers solutions for miniaturizing chips. Its products are used to manufacture chips which are used in smartphones, tablets, computers, IT servers and data centers, electronic components in cars, conn …
  • Inception Sciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Inception Sciences Inc (Inception Sciences) is a pharmaceutical company that offers drug discovery incubators. The company develops new companies in partnership with academic researchers and biopharmaceutical companies. It develops drugs for various indications such as fibrotic diseases, onc …
  • Meiji Seika Pharma Co Ltd：企業のM&A・事業提携・投資動向
    Meiji Seika Pharma Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Meiji Seika Pharma Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • TYI 2011 Ltd：企業の戦略的SWOT分析
    TYI 2011 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Dentsu Inc. (4324)：企業の財務・戦略的SWOT分析
    Dentsu Inc. (4324) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Itamar Medical Ltd (ITMR)-医療機器分野：企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • Aura Energy Ltd (AEE)：企業の財務・戦略的SWOT分析
    Summary Aura Energy Ltd (Aura Energy) is a mining and mineral exploration and development company. The company’s business activities include acquisition, exploration, and development of uranium properties in Europe and Africa. Its projects comprise Haggan Uranium Project, Kallsedet Uranium Project, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆